2-Pyridinecarboxamide,5-(8-chloro-3-isoquinolinyl)-N-methyl-
98%
- Product Code: 228015
CAS:
2197909-45-6
Molecular Weight: | 297.74 g./mol | Molecular Formula: | C₁₆H₁₂ClN₃O |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | Room temperature, seal, dry |
Product Description:
Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly those targeting tyrosine kinases involved in cancer cell proliferation. Shows potential in the development of anti-tumor agents due to its ability to cross cell membranes and inhibit specific signaling pathways. Also employed in studies focused on improving selectivity and potency of anti-inflammatory and anti-angiogenic drugs. Its structure supports binding to ATP pockets in enzymes, making it valuable in designing targeted therapies.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
100mg | 10-20 days | ฿43,600.00 |
+
-
|
2-Pyridinecarboxamide,5-(8-chloro-3-isoquinolinyl)-N-methyl-
Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly those targeting tyrosine kinases involved in cancer cell proliferation. Shows potential in the development of anti-tumor agents due to its ability to cross cell membranes and inhibit specific signaling pathways. Also employed in studies focused on improving selectivity and potency of anti-inflammatory and anti-angiogenic drugs. Its structure supports binding to ATP pockets in enzymes, making it valuable in designing targeted therapies.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :